Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Enzo Life Sciences, has unveiled an immunoassay (ELISA) system which can be used to detect Survival Motor Neuron (SMN) protein.
Subscribe to our email newsletter
The SMN ELISA kit will enable and expedite drug discovery, development and therapy for Spinal Muscular Atrophy, a genetic cause of mortality in infants and toddlers.
The SMN ELISA Kit offers a reliable measure of SMN protein levels, and accelerates efficacy assessment of potential drugs in clinical trials that are designed to increase SMN protein levels.
The assay has been validated for use with human and mouse cell lysates and tissue homogenates, and will be marketed through Enzo’s worldwide sales and marketing group.